z-logo
Premium
Molecular Insight and Mode of Inhibition of α ‐Glucosidase and α ‐Amylase by Pahangensin A from Alpinia pahangensis Ridl.
Author(s) -
Loo Kong Yong,
Leong Kok Hoong,
Sivasothy Yasodha,
Ibrahim Halijah,
Awang Khalijah
Publication year - 2019
Publication title -
chemistry and biodiversity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 70
eISSN - 1612-1880
pISSN - 1612-1872
DOI - 10.1002/cbdv.201900032
Subject(s) - chemistry , diterpene , enzyme , ic50 , rhizome , amylase , active site , biochemistry , docking (animal) , inhibitory postsynaptic potential , active compound , stereochemistry , traditional medicine , in vitro , biology , medicine , nursing , neuroscience
The inhibition of carbohydrate‐hydrolyzing enzymes in human digestive organs is crucial in controlling blood sugar levels, which is important in treating type 2 diabetes. In the current study, pahangensin A ( 1 ), a bis‐labdanic diterpene characterized previously in the rhizomes of Alpinia pahangensis Ridl ., was identified as an active dual inhibitor for α ‐amylase (IC 50 =114.80 μ m ) and α ‐glucosidase (IC 50 =153.87 μ m ). This is the first report on the dual α ‐amylase and α ‐glucosidase inhibitory activities of a bis‐labdanic diterpene. The Lineweaver‐Burk plots of compound 1 indicate that it is a mixed‐type inhibitor with regard to both enzymes. Based on molecular docking studies, compound 1 docked in a non‐active site of both enzymes. The dual inhibitory activity of compound 1 makes it a suitable natural alternative in the treatment of type 2 diabetes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom